Cleopatra Hospitals Group results, Q4 2023
Net profit, assets, equity and cash flow for Q4 2023, against the same period a year earlier, from the published financial statements.
Net profit107 millionEGP · +36.0% vs the same period a year earlier
Total assets4.49 billionEGP · +36.7% vs the same period a year earlier
Shareholders' equity2.45 billionEGP · +20.7% vs the same period a year earlier
Operating cash flow161 millionEGP · +32.5% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Q4 2023 was about 107 million EGP, up +36.0% from 78.83 million EGP in Q4 2022.
- Total assets at the end of Q4 2023 were about 4.49 billion EGP, and shareholders' equity about 2.45 billion EGP.
- Operating cash flow for Q4 2023 was positive at 161 million EGP.
Key lines against the same period a year earlier
This periodQ4 2022Change
Net profit107 million78.83 million+36.0%
Gross profit408 million273 million+49.1%
Total assets4.49 billion3.28 billion+36.7%
Total liabilities2.04 billion1.26 billion+62.6%
Shareholders' equity2.45 billion2.03 billion+20.7%
Total liabilities and equity4.49 billion3.28 billion+36.7%
Operating cash flow161 million122 million+32.5%
Investing cash flow-290 million-161 million−80.0%
Financing cash flow153 million20.63 million+640.3%
Net change in cash24.35 million-18.53 million+231.4%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy